Brutal Killing

  • Most Popular
  • Most Shared

Reuters Showcase

Oklahoma Tornado

Oklahoma Tornado

Oklahoma tornado victims astounded at how they survived  Full Article | Slideshow 

Syrian Crisis

Syrian Crisis

West may boost Syria rebels if Assad won't talk peace.  Full Article 

Defiant Iran

Defiant Iran

Iran pushes ahead with nuclear plant that worries West.  Full Article 

U.S. Drone Strikes

U.S. Drone Strikes

U.S. acknowledges killing four Americans in drone strikes.  Full Article 

Stockholm Riots

Stockholm Riots

Stockholm riots challenge image of happy, generous state.  Full Article 

Marathon Bombings

Marathon Bombings

FBI says man shot dead while being questioned about Boston bombings.  Full Article 

China-U.S. Ties

China-U.S. Ties

Analysis: From opera to exercises, U.S. and China deepen military ties.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage 

Italian Nobel scientist Montalcini dies at 103

Related Topics

Brazil monks' message of humility

Brazil monks' message of humility

A religious fraternity in Rio considers the election of Pope Francis, the first pontiff to take the name of St Francis of Assisi, a confirmation of their beliefs in poverty and simplicity.  Slideshow 

Italian senator and Nobel prize winner Rita Levi Montalcini votes during the fourth round of votes to elect the new Senate speaker in Rome April 29, 2006. REUTERS/Max Rossi/Files

Italian senator and Nobel prize winner Rita Levi Montalcini votes during the fourth round of votes to elect the new Senate speaker in Rome April 29, 2006.

Credit: Reuters/Max Rossi/Files

ROME | Mon Dec 31, 2012 8:42am IST

ROME (Reuters) - Rita Levi Montalcini, joint winner of the Nobel Prize for Medicine and an Italian Senator for Life, died on Sunday at the age of 103, her family said.

The first Nobel laureate to reach 100 years of age, she won the prize in 1986 with American Stanley Cohen for their discovery of nerve growth factor (NGF), a protein that makes developing cells grow by stimulating surrounding nerve tissue.

Her research helped in the treatment of spinal cord injuries and has increased understanding of cardiovascular diseases, Alzheimer's and conditions such as dementia and autism.

One of twins born to a Jewish family in Turin in 1909, Montalcini was the oldest living recipient of the prize.

During World War Two, the Allies' bombing of Turin forced her to flee to the countryside where she established a mini-laboratory. She fled to Florence after the German invasion of Italy and lived in hiding there for a while, later working as a doctor in a refugee camp.

After the war she moved to St. Louis in the United States to work at Washington University, where she went on to make her groundbreaking NGF discoveries.

She also set up a research unit in Rome and in 1975 became the first woman to be made a full member of the Vatican's Pontifical Academy of Sciences in 1975. She won several other awards for her contributions to medical and scientific research.

Her face was instantly recognisable in Italy and she was well known as a dignified and respected intellectual, a counterbalance to the image of women succeeding through their looks and sexuality, exacerbated during the scandal-plagued era of former prime minister Silvio Berlusconi.

Two days after her birthday in April this year she posted a note on Facebook saying it was important never to give up on life or fall into mediocrity and passive resignation.

"I've lost a bit of sight, and a lot of hearing. At conferences I don't see the projections and I don't feel good. But I think more now than I did when I was 20. The body does what it wants. I am not the body, I am the mind," she said.

Italian Prime Minister Mario Monti said in a statement that Montalcini's Nobel prize had been an honour for Italy, and praised her efforts to encourage young people, especially women, to play a central role in scientific research.

(Editing by Louise Ireland)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.